Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.88 +0.00 (+0.27%)
As of: Sep 30, 2026 · 10:25 AM EDT

Lexicon Pharmaceuticals (LXRX) Non-Current Debt (2010 - 2026)

Updated

Lexicon Pharmaceuticals (LXRX) reported Non-Current Debt of $49.96 million for FY2023, up 2.2% from $48.87 million in FY2022.

Analysis

Lexicon Pharmaceuticals (LXRX) Non-Current Debt (2010 - 2026) Analysis & Trends

  • According to Business Quant data, Non-Current Debt came in at $48.87 million in FY2022 and -$11.7 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Lexicon Pharmaceuticals 849.05 Mn 275.61 Mn 653,000.00 51.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.44 Mn
Mar 31, 2026 49.68 Mn
Dec 31, 2025 49.41 Mn
Sep 30, 2025 56.51 Mn
Jun 30, 2025 56.11 Mn
Mar 31, 2025 58.64 Mn
Dec 31, 2024 100.30 Mn
Sep 30, 2024 99.90 Mn
Jun 30, 2024 99.50 Mn
Mar 31, 2024 99.90 Mn
Dec 31, 2023 99.51 Mn
Sep 30, 2023 99.27 Mn
Jun 30, 2023 98.77 Mn
Mar 31, 2023 48.85 Mn
Dec 31, 2022 48.58 Mn
Sep 30, 2022 23.78 Mn
Jun 30, 2022 23.63 Mn
Mar 31, 2022 23.48 Mn
Sep 30, 2020 11.63 Mn
Jun 30, 2020 234.81 Mn
API Access

Lexicon Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=LXRX&period=max&api_key=YOUR_API_KEY